MTP XIX: CLL – MRD: Present and Future 

Session Chair: Paolo Ghia, MD, PhD

• Advantages/Disadvantages of Various MRD Techniques | Andy C. Rawstron, PhD | Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom
• Rational Decision Making Based on the Molecular Landscape | William Wierda, MD, PhD | MD Anderson Cancer Center, Houston, Texas, USA
• MRD Relapse, Time to Treat? | Carsten Niemann, MD, PhD | Copenhagen University Hospital, Copenhagen, Denmark